CONNECT WITH US:
May 31, 2019 08:00 JST
Novotech Awarded Asia-Pacific Biotech CRO of the Year - Announced at ASCO
SYDNEY, May 31, 2019 - (ACN Newswire) - Novotech, the Asia-Pacific CRO, has again won the prestigious Asia-Pacific CRO of the year awarded by leading analyst firm Frost & Sullivan. This is the fifth year Novotech has been awarded the top CRO for the region which focusses on best practices in clinical research for biotechs.
The announcement was made at the ASCO Annual Meeting (May 31 - June 4, 2019 McCormick Place, Chicago, IL)
Dinesh Sampath Rangaraj, Vice President Healthcare, Frost & Sullivan said: "Novotech is internationally recognized as a leading regional full-service CRO in Asia- Pacific. The company has achieved colossal success in Phase I through IV clinical trials and established itself as a specialized biotech CRO in the region. In addition, with its international accreditation coupled with local knowledge, partnerships, and expertise, Novotech has reinforced its presence in Asia-Pacific."
Novotech CEO Dr John Moller said he was extremely pleased the company had again been recognized as the leader in the region.
"Novotech is growing rapidly due to its reputation for specialist teams on the ground with local knowledge, partnerships and expertise.
"Staff numbers in Asia have grown by 20% since December. We now have 600 Novotech people delivering excellence in clinical research management and monitoring," he said.
Novotech has been delivering CRO services in the region for more than 23 years and now has offices in 11 countries to accommodate increased demand from USA biotechs for specialist clinical services.
Novotech works in partnership with the leading medical institutions across Asia to accelerate quality clinical research for its clients and has now signed 19 strategic partnerships with hospitals and research institutions in the region.
Novotech acquired Australasian specialist CRO Clinical Network Services (CNS) as part of a mutual mission to expand services to biopharma for early phase product development and clinical research in Australia, through to later Phase regional and global trials.
Novotech's Asia-Pacific clinical research offers:
- Large patient population
- Few competing trials
- Efficient regulatory system
- Highly qualified and educated medical professionals
- Low operational costs
- Well supported IT infrastructure
- High level of GCP compliance
- Efficient trial management and logistics infrastructure
"Our customers value our regional CRO capabilities and our local in country knowledge and leadership where we can work across and understand local cultures, customs, and regulations, and we have developed deep relationships with the key investigators in the region," said Dr Moller.
About Novotech -
Headquartered in Sydney, Novotech is internationally recognized as the leading regional full-service contract research organization (CRO). Novotech has been instrumental in the success of hundreds of Phase I - IV clinical trials in the Asia Pacific region.
Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor management. Novotech's strong Asia Pacific presence includes running clinical trials in all key regional markets. Novotech also has worldwide reach through the company's network of strategic partners.
For RFP enquiries: Please fill out the form available at www.novotech-cro.com/contact-us-0
AU: +61 2 8218 2144
USA: +1 415 951 3228
Asia: +65 3159 3427
Copyright ©2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Fujitsu Launches 14 New Models of Enterprise Notebooks, Tablets and Workstations Optimized for Remote Work
May 26, 2020 11:10 JST
Fujitsu Develops AI-Video Recognition Technology to Promote Hand Washing Etiquette and Hygiene in the Workplace
May 26, 2020 10:34 JST
Mitsubishi Motors Joins OPEN COVID-19 DECLARATION
May 26, 2020 09:34 JST
Tokyo Metropolitan Government to trial 5G Antenna-equipped Smart Poles in Cooperation with Sumitomo Corporation and NEC
May 25, 2020 10:44 JST
Mazda Begins Providing, Virtual Racing Car, Mazda RX-Vision GT3 Concept Online
May 22, 2020 14:26 JST
'e5 Consortium' Established to Promote Zero-Emission Electric Vessel
May 21, 2020 15:34 JST
TOYOTA GAZOO Racing Decides Not to Participate in 2020 Edition of Nurburgring 24 Hours
May 21, 2020 14:19 JST
Fujitsu RunMyProcess Drives Next Phase of Digital Transformation in Business Processes with DigitalSuite ProcessModeler
May 21, 2020 09:00 JST
MHPS Captures Global Gas Turbine Market Share Leadership Again
May 20, 2020 10:09 JST
Hitachi Awarded Contract to Supply, Install 300 Lifts at HDB Blocks in Singapore
May 19, 2020 11:57 JST
DENSO, Global Mobility Service to Support Delivery of COVID-19 Test Kits in Indonesia
May 18, 2020 17:36 JST
Eisai to Launch New Selbelle Premium Tablets and New Selbelle Premium Fine Granules
May 18, 2020 13:33 JST
Hitachi to Provide $1 Million in Loans through Kiva to Businesses in Need around the Globe, Affected by the Spread of the COVID-19
May 18, 2020 13:24 JST
Toyota's Adjustments to Domestic Production in June 2020 (as of May 15)
May 15, 2020 17:01 JST
Transgene and NEC Demonstrate High Accuracy of AI-based Neoantigen Prediction for the Design of Individualized Cancer Vaccine TG4050
May 15, 2020 14:10 JST
Fujitsu and Accenture Collaboration Accelerates Reliable Blockchain Interoperability
May 15, 2020 10:11 JST
Mazda Releases FY March 2020 Full Year Financial Results
May 14, 2020 17:01 JST
Fujitsu Sets Out the 'Fujitsu Technology and Service Vision 2020'
May 14, 2020 15:53 JST
Notice of Agreement for the Merger through Absorption (Simplified Absorption-type Merger) of a Consolidated Subsidiary of Fujitsu Limited
May 14, 2020 15:46 JST
Eisai to Present Data on Oncology Pipeline and Products at ASCO20 Annual Meeting
May 14, 2020 09:22 JST
More Latest Release >>
Novotech Selected as CRO for Karyopharm's COVID-19 Clinical Study
April 29 2020 21:00 JST
Novotech COVID-19 Clinical Trial Clients Benefit from New Asia-Pacific Fast-Track Review Processes
April 28 2020 19:00 JST
Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity
April 08 2020 18:00 JST
Novotech CRO Tapped for Two Informa Citeline Awards for Excellence in Asia-Pacific Clinical Trials
March 20 2020 20:30 JST
Novotech Wins CRO Contract for Komipharm Coronavirus Covid-19 Clinical Trial in South Korea
March 06 2020 22:00 JST
Asia-Pacific has Record Year for Clinical Trials says Novotech CRO
January 21 2020 10:40 JST
Novotech CRO partners Skin Research Institute of Singapore (SRIS) for Skin Disorder Research
July 11 2019 11:00 JST
Novotech CRO strengthens South Korean Clinical Capabilities, partners with 2 Major Hospitals
April 18 2019 04:00 JST
Novotech CNS USA Appoints Dr Robert Malone to its Washington, DC BioDesk
March 25 2019 18:00 JST
Novotech CRO Launches Largest Oracle Trial Management and Monitoring Cloud Service Implementation in Asia-Pacific
December 17 2018 08:00 JST
More Press release >>